Darío de Jesús Guillén-Morales

Darío de Jesús Guillén-Morales

Biomedicina experimental, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca, Mexico
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2025 in Hygiene
Verified
Journal Article
Open access
PDF file
Darío de Jesús Guillén-MoralesDarío de Jesús Guillén-Morales
Darío de Jesús Guillén-Morales
ICIsabel Cruz-Cortés
Isabel Cruz-Cortés
TSTaurino Amilcar Sosa-Velazco
Taurino Amilcar Sosa-Velazco
Alba Soledad Aquino-DominguezAlba Soledad Aquino-Dominguez
Alba Soledad Aquino-Dominguez
Breastfeeding is a complex biological system and a bidirectional physiological dialogue in which the infant may contribute to maternal breast health. This review synthesizes current evidence, clearly separating established findings from emerging hypotheses, to examine the possible infant-driven mechanisms that influence hormonal and immune homeostasis in the mammary gland. We evaluate how neonatal suckling coordinates interconnected hormonal reflexes and immune activity, and we explore the hypothesis that the retrograde flow of infant saliva to the breast tissue could activate maternal enzymatic defenses, particularly the xanthine oxidase and lactoperoxidase systems. We also consider the activation of antimicrobial peptides through direct contact at the nipple and areola, including cathelicidin and defensins, as well as the potential roles of fetal microchimerism and microbial transfer from the infant’s mouth in strengthening breast resilience. Although much of the evidence remains indirect and based on in vitro and animal models, the convergence of data supports a reformulated conceptual model that presents the infant as an active physiological partner rather than a passive recipient of milk. Recognizing this shift has important clinical implications for the prevention of inflammatory conditions such as mastitis, the improvement of breastfeeding support strategies, and the optimization of maternal and infant health outcomes. The review also identifies significant gaps in current knowledge and cautiously proposes hypotheses to explore these mechanisms. While preliminary, this framework offers an original perspective that may guide future research and open new paths in the study of human lactation biology.

Verified
Journal Article
Open access
PDF file
Diego Sait Cruz-HernándezDiego Sait Cruz-Hernández
Diego Sait Cruz-Hernández
FPFRANCISCO JAVIER SANCHEZ PEÑA
FRANCISCO JAVIER SANCHEZ PEÑA
Marymar Cruz CruzMarymar Cruz Cruz
Marymar Cruz Cruz
Darío de Jesús Guillén-MoralesDarío de Jesús Guillén-Morales
Darío de Jesús Guillén-Morales
MSMartha Cristina Castillo Soriano
Martha Cristina Castillo Soriano
SASergio Roberto Aguilar-Ruíz
Sergio Roberto Aguilar-Ruíz
Dengue virus (DENV) affects not only peripheral immune cells but also hematopoietic progenitors in the bone marrow, particularly megakaryocytic precursors, which contribute to the thrombocytopenia characteristic of the disease. In this study, we evaluated the relationship between the differentiation status of the megakaryocytic lineage and its permissiveness and antiviral response to DENV. Our results demonstrate that the erythroid–megakaryocytic precursor (K562 cells) was more permissive to DENV infection than megakaryoblasts, as evidenced by immunofluorescence, flow cytometry, and quantification of viral particles. The antiviral response in K562 cells peaked at three days post-infection, with maximal expression of genes associated with the type I interferon (IFN-I) pathway. In vitro-induced differentiation of K562 cells reduced the initial susceptibility to DENV and enhanced the expression of Toll-like receptor 3 (TLR3) and the type I interferon receptor (IFNAR1), accelerating and intensifying IFN-β secretion, and increasing the expression of OAS2 and IRF3. Furthermore, pretreatment of K562 cells with recombinant IFN-β significantly reduced viral replication from the first day post-infection. Collectively, these findings demonstrate for the first time that the differentiation status of erythroid–megakaryocytic progenitor critically shapes their antiviral response and underscore the central role of IFN-β in the early restriction of DENV infection.

26 July 2026 in Exploration of Drug Science
Verified
Journal Article
Open access
PDF file
Alba Soledad Aquino-DominguezAlba Soledad Aquino-Dominguez
Alba Soledad Aquino-Dominguez
NSNora Patricia Sánchez-Chávez
Nora Patricia Sánchez-Chávez
SASergio Roberto Aguilar-Ruiz
Sergio Roberto Aguilar-Ruiz
ALAbimael López-Hernández
Abimael López-Hernández
Darío de Jesús Guillén-MoralesDarío de Jesús Guillén-Morales
Darío de Jesús Guillén-Morales
GHGuillermo Hernández-Jiménez
Guillermo Hernández-Jiménez
Human milk is widely recognized as the biological standard for early-life nutrition, providing both essential nutrients and bioactive components that support immune development. However, breastfeeding is not always feasible, and infant formula remains a necessary alternative in specific clinical and social contexts. Despite advances in formulation, significant immunological differences persist between breastfed and formula-fed infants, contributing to the so-called “immunological gap.” This review critically examines the potential of human milk-derived antimicrobial peptides (HM-AMPs) as functional ingredients to partially address this gap. Current evidence indicates that these peptides, derived from proteins such as lactoferrin, caseins, and α-lactalbumin, exhibit antimicrobial and immunomodulatory activities through mechanisms including membrane disruption and modulation of inflammatory pathways. However, most available data are derived from in vitro and preclinical models, limiting direct translation to clinical outcomes. In addition, significant challenges remain, including peptide instability during industrial processing, uncertain bioavailability in the gastrointestinal tract, and limited clinical validation. While emerging computational and bioengineering strategies offer opportunities to optimize peptide functionality, their large-scale implementation remains constrained by technological and regulatory factors. Overall, HM-AMPs represent a promising but still developing approach to improving infant formula functionality. Their contribution should be interpreted as partial and context-dependent, rather than as a complete replication of the immunological properties of human milk.